Última Hora: "Portugal deve rever lei laboral para promover contratos permanentes, afirma Bruxelas - Observador" Wed, 23 May 2018 13:42:00 GMT   "" Wed, 23 May 2018 20:56:45 GMT    "Comida para caridade abandonada em monte de Guimarães - PT Jornal" Wed, 23 May 2018 14:09:28 GMT    "Portugal é o país que mais subiu no ranking mundial da competitividade - Expresso" Wed, 23 May 2018 20:01:00 GMT    "'Jackpot' de 57 milhões de euros no próximo sorteio do Euromilhões - Correio da Manhã" Tue, 22 May 2018 21:20:27 GMT    "Obras na A1 entre Sacavém e Vila Franca a partir de segunda-feira - TVI24" Wed, 23 May 2018 16:47:00 GMT    "Novas regras de proteção de dados: Da myTaxi à Nos, as empresas estão prontas para a mudança? - ECO Economia Online" Wed, 23 May 2018 17:10:29 GMT    "Ministro adjunto garante que nunca se reuniu com a China Three Gorges - Renascença" Wed, 23 May 2018 13:07:04 GMT    "Volume de exportações de Braga cresceu 35% - Expresso" Wed, 23 May 2018 19:25:00 GMT    "Ferroviários fazem greve a 4 de junho contra agente único nos comboios - Observador" Wed, 23 May 2018 17:32:21 GMT      Para mais notícias, clique aqui.

Área de Acesso
       
       
Lembrar Sempre 
(Login BolsaPT & Canal Forex)

Procure análises técnicas no nosso fórum aqui: Análises Técnicas
Nota: Os dados após 2009-10-29 são ainda temporários e poderão por isso ter o valor de Abertura errado até nova actualização...
Mudar para Gráfico Estático de Sepracor Inc.

Sem variação
Sepracor Inc. - [Ticker: SEPR]Gráfico Sepracor Inc.  Notícias Sepracor Inc.  Download de Históricos Metastock Sepracor Inc. e Outros  Análise Técnica Sepracor Inc.  
Última Trade0,000Range 52 Semanas[0,000 - 0,000]
Hora da Última Trade - 00:00:00Price-Target 1 Ano0,000
VariaçãoN/A (N/A)Capitalização Bolsista0
Bid / AskN/AEPS0,00
Abertura0,000PER0,00%
Máximo0,000Pagamento Dividendo
Mínimo0,000Data Ex-Dividendo
Fecho Anterior0,000Yield
Volume0Volume Médio (3m)0
Nota: Os dados podem apresentar atraso de alguns minutos.

 Notícias sobre Sepracor Inc. [SEPR]:   (ordenadas por relevância)

Business Wire (press release)

Entasis Therapeutics Appoints David C. Hastings to Board of Directors
Business Wire (press release)
BUSINESS WIRE)--Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced the appointment of David C. Hastings to the company's Board of ...

e mais »

Business Wire (press release)

Rodin Therapeutics Expands Leadership Team, Adding Extensive Experience in Clinical and Business Development
Business Wire (press release)
She then joined Sunovion Pharmaceuticals, Inc. (formerly Sepracor), moving through positions of increasing responsibility into the role of vice president for corporate development and licensing. Sullivan played an instrumental role in the company's ...


Form DEF 14A Aralez Pharmaceuticals For: Jun 29
StreetInsider.com
You are cordially invited to attend the 2018 Annual Meeting of Shareholders (the "Meeting") of Aralez Pharmaceuticals Inc. ("Aralez" or the "Company") on Friday, June 29, 2018, at 9:00 a.m. (Eastern Standard Time) at the offices of Stikeman Elliott LLP ...


Innovative Add-On Treatments for Schizophrenia: May 2018
Healio
Sponsorship Statement: This CME activity is jointly sponsored by AKH Inc., Advancing Knowledge in Healthcare and Psychiatric Annals. ... Faculty members report the following financial relationships: Andrew A. Nierenberg, MD, has disclosed the following ...


Allergy Treatment Market to See Incredible Growth During 2016-2026
The Financial Analyst
... market are Allergy therapeutics, Allergopharma, Allergon AB, Alerpharma S.A, Allergan, Inc., Genentech Inc., Schering-Plough Corporation, McNeil Consumer Healthcare, Collegium Pharmaceutical, Inc., Meda Pharmaceuticals, Inc, Sepracor, Inc. and ...

e mais »

Business Wire (press release)

Kala Pharmaceuticals Strengthens Commercial Organization in Preparation for First Product Launch
Business Wire (press release)
BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of product candidates using its proprietary mucus-penetrating particle (MPP) technology, today announced the ...


Global Loratadine Market 2018 Share- Sandoz, Mylan and Sepracor
The Columnist
... Loratadine Market based on Key Players: This part figures out the Loratadine market on the basis of top manufacturers which includes Pfizer, Teva, Apollo Pharmaceuticals, GSK, Sepracor, Novartis India Limited, Sandoz, Mylan and Mayne Pharma Inc.

e mais »

United States Asthma Medication Market Report 2018-2025
The Mobile Herald
Inc, AstraZeneca plc, Roche Holdings Ltd, Genentech Inc, Sepracor, Inc, Schering-Plough Corp, Sanofi-Aventis, Theravance Inc. On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type ...


BSA bureau (press release)

Sumitomo Dainippon appoints Nomura as President & CEO
BSA bureau (press release)
In 2010, Sunovion (formerly Sepracor Inc.), was acquired by Sumitomo Dainippon. Nomura took the position of the Vice Chair, Executive Vice President and CFO, Sunovion Pharmaceuticals Inc. in 2012. Following 2014, he became associated with the ...

e mais »

Allergy Treatment Market: Global Industry Analysis and Opportunity Assessment 2016-2026
Healthcare Journal
... market are Allergy therapeutics, Allergopharma, Allergon AB, Alerpharma S.A, Allergan, Inc., Genentech Inc., Schering-Plough Corporation, McNeil Consumer Healthcare, Collegium Pharmaceutical, Inc., Meda Pharmaceuticals, Inc, Sepracor, Inc. and ...

e mais »

Business Wire (press release)

Kala Pharmaceuticals Appoints Eric Trachtenberg as General Counsel and Corporate Secretary
Business Wire (press release)
Prior to Auxilium, he was Vice President, General Counsel and Corporate Secretary of Enobia Pharma, Inc. Prior to that, Mr. Trachtenberg served as Vice President and Associate General Counsel of Sepracor Inc. (now known as Sunovion Pharmaceuticals ...

e mais »

Kala Pharmaceuticals Appoints Todd Bazemore as Chief Operating Officer
Business Wire (press release)
Prior to joining Dyax, Todd was at Sunovion Pharmaceuticals, Inc. (previously Sepracor Inc., prior to its acquisition by Sumitomo Dainippon Pharma Co., Ltd), where he served in several roles of increasing responsibility including Vice President ...

e mais »

Newcanaanitect.com

Global Desloratadine Market 2018: Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan
Newcanaanitect.com
Moreover, the list of major companies/competitors is also present including Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc . The competition data allows users to gauge ...


Form DEF 14A Spero Therapeutics, Inc. For: Jun 05
StreetInsider.com
You are cordially invited to attend the 2018 annual meeting of stockholders of Spero Therapeutics, Inc. to be held at 9:00 a.m. ET on Tuesday, June 5, 2018 at the offices of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. at One Financial Center ...

e mais »

Drugmakers Duped Medicaid Rebate Regulators, 3rd Circ. Told
Law360
Law360, Philadelphia (April 12, 2018, 4:25 PM EDT) -- A pharmaceutical executive urged the Third Circuit on Wednesday to revive his suit alleging Allergan Inc. and other companies shorted the federal government on drug rebate payments, arguing that the ...

e mais »
Para mais notícias sobre Sepracor Inc. clique aqui:
Notícias de Sepracor Inc. 


Largura do Site:

 Imagem de Fundo:

Copyright@1998-2018 - BolsaPT.com, todos os direitos reservados.
Fórum de Bolsa Cotações de Bolsa Notícias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters